Baijin Life Science schedules board meeting to review full-year results and final dividend recommendation

Baijin Life Science Holdings has scheduled a board meeting for June 30, 2026. The primary agenda items include reviewing the final results for the fiscal year ended March 31, 2026, and considering a recommendation regarding the final dividend.

Baijin Life Science Holdings schedules a board meeting for June 30, 2026 to review final results for the year ended March 31, 2026. * Directors will also consider a recommendation on a final dividend. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Baijin Life Science Holdings Limited published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260617-12206339), on June 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)